Correlation Between Protagenic Therapeutics and Mink Therapeutics

Can any of the company-specific risk be diversified away by investing in both Protagenic Therapeutics and Mink Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Protagenic Therapeutics and Mink Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Protagenic Therapeutics and Mink Therapeutics, you can compare the effects of market volatilities on Protagenic Therapeutics and Mink Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Protagenic Therapeutics with a short position of Mink Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Protagenic Therapeutics and Mink Therapeutics.

Diversification Opportunities for Protagenic Therapeutics and Mink Therapeutics

0.57

Correlation Coefficient

Protagenic Therapeutics  Mink Therapeutics

Very weak diversification

The 3 months correlation between Protagenic and Mink is 0.57. Overlapping area represents the amount of risk that can be diversified away by holding Protagenic Therapeutics and Mink Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Mink Therapeutics and Protagenic Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Protagenic Therapeutics are associated (or correlated) with Mink Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Mink Therapeutics has no effect on the direction of Protagenic Therapeutics i.e., Protagenic Therapeutics and Mink Therapeutics go up and down completely randomly.

Pair Corralation between Protagenic Therapeutics and Mink Therapeutics

Given the investment horizon of 90 days Protagenic Therapeutics is expected to generate 4.51 times more return on investment than Mink Therapeutics. However, Protagenic Therapeutics is 4.51 times more volatile than Mink Therapeutics. It trades about -0.05 of its potential returns per unit of risk. Mink Therapeutics is currently generating about -0.32 per unit of risk. If you would invest  58.00  in Protagenic Therapeutics on September 17, 2024 and sell it today you would lose (8.00) from holding Protagenic Therapeutics or give up 13.79% of portfolio value over 90 days.

Time Period	3 Months [change]
Direction	Moves Together
Strength	Weak
Accuracy	100.0%
Values	Daily Returns

Protagenic Therapeutics  vs.  Mink Therapeutics

Protagenic Therapeutics

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days Protagenic Therapeutics has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of latest weak performance, the Stock's forward indicators remain strong and the current disturbance on Wall Street may also be a sign of long term gains for the company investors.

Mink Therapeutics

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days Mink Therapeutics has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of inconsistent performance in the last few months, the Stock's forward-looking signals remain comparatively stable which may send shares a bit higher in January 2025. The newest uproar may also be a sign of mid-term up-swing for the firm private investors.

Pair Trading with Protagenic Therapeutics and Mink Therapeutics

The main advantage of trading using opposite Protagenic Therapeutics and Mink Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Protagenic Therapeutics position performs unexpectedly, Mink Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Mink Therapeutics will offset losses from the drop in Mink Therapeutics' long position.

The idea behind Protagenic Therapeutics and Mink Therapeutics pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Bond Analysis module to evaluate and analyze corporate bonds as a potential investment for your portfolios..